LEO 158968
/ LEO Pharma, Novartis
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
September 18, 2025
LP0189-2318: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968
(clinicaltrials.gov)
- P1 | N=6 | Completed | Sponsor: LEO Pharma | Active, not recruiting ➔ Completed
Trial completion • Gout • Inflammation • Inflammatory Arthritis • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Pain • Rheumatology
July 17, 2025
LP0189-2318: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968
(clinicaltrials.gov)
- P1 | N=6 | Active, not recruiting | Sponsor: LEO Pharma | Recruiting ➔ Active, not recruiting | N=15 ➔ 6
Enrollment change • Enrollment closed • Gout • Inflammation • Inflammatory Arthritis • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Pain • Rheumatology
May 03, 2025
LP0189-2318: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: LEO Pharma | Trial completion date: Feb 2025 ➔ Oct 2025 | Trial primary completion date: Feb 2025 ➔ Oct 2025
Trial completion date • Trial primary completion date • Gout • Inflammation • Inflammatory Arthritis • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Pain • Rheumatology
October 02, 2024
LP0189-2318: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: LEO Pharma | Not yet recruiting ➔ Recruiting
Enrollment open • Gout • Inflammation • Inflammatory Arthritis • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Pain • Rheumatology
August 22, 2024
Investigating the Safety of LEO 158968 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=120 | Completed | Sponsor: LEO Pharma | Active, not recruiting ➔ Completed
Trial completion
June 06, 2024
A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968
(clinicaltrials.gov)
- P1 | N=15 | Not yet recruiting | Sponsor: LEO Pharma
New P1 trial • Gout • Inflammation • Inflammatory Arthritis • Musculoskeletal Diseases • Musculoskeletal Pain • Orthopedics • Pain • Rheumatology
April 24, 2024
Investigating the Safety of LEO 158968 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=120 | Active, not recruiting | Sponsor: LEO Pharma | Suspended ➔ Active, not recruiting
Enrollment closed
1 to 7
Of
7
Go to page
1